Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

10 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Protocol IIIA AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIIA AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 4 Itemgroepen, 32 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIIA. Clinical Trial Number: NCT01117441.

Protocol IB AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 4 Itemgroepen, 21 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB. Clinical Trial Number: NCT01117441.

Protocol IIA AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIA AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 5 Itemgroepen, 31 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIA. Clinical Trial Number: NCT01117441.

Protocol IB AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 4 Itemgroepen, 21 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB. Clinical Trial Number: NCT01117441.

Protocol IAD AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IAD AIEOP-BFM ALL 2009 NCT01117441

- 15-05-16 - 1 Formulier, 4 Itemgroepen, 33 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IAD (Study Protocol IA with Dexamethasone). Clinical Trial Number: NCT01117441.

Protocol IIB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 5 Itemgroepen, 28 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIB (Study Protocol IIB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Protocol IB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 5 Itemgroepen, 33 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB (Study Protocol IB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Protocol IB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 5 Itemgroepen, 28 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB (Study Protocol IB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Protocol IA-CPM AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IA-CPM AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 4 Itemgroepen, 33 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IA-CPM (Study Protocol IA with additional Cyclophosphamid). Clinical Trial Number: NCT01117441.

Protocol IA AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IA AIEOP-BFM ALL 2009 NCT01117441

- 21-05-16 - 1 Formulier, 5 Itemgroepen, 31 Data-elementen, 1 Taal
Itemgroepen: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IA (Study Protocol IA: 4 doses of Daunorubicin, Study Protocol IA': 2 doses of Daunorubicin). Clinical Trial Number: NCT01117441.

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial